Literature DB >> 30126952

Short-Term Peripheral Venous Catheter-Related Bloodstream Infections: Evidence for Increasing Prevalence of Gram-Negative Microorganisms from a 25-Year Prospective Observational Study.

Marco Ripa1,2, Laura Morata2, Olga Rodríguez-Núñez2, Celia Cardozo2, Pedro Puerta-Alcalde2, Marta Hernández-Meneses2, Juan Ambrosioni2, Laura Linares2, Marta Bodro2, Andrea Valcárcel3, Climent Casals4, Maria de Los Angeles Guerrero-León2, Manel Almela4, Carolina Garcia-Vidal2, Ana Del Río2, Francesc Marco4, Josep Mensa2, José Antonio Martínez2, Alex Soriano5.   

Abstract

The aim of this study was to describe the etiology and outcome of short-term peripheral venous catheter (PVC)-related bloodstream infections (PVCRBSI) in a 25-year period (1992 to 2016) and to identify predictive factors of Gram-negative PVCRBSI. This was a prospective observational study including all episodes of PVCRBSI. A multivariate logistic regression model adjusted for calendar year was built to explore factors associated with a Gram-negative bacterial etiology. Over the study period, 711 episodes of PVCRBSI were identified. Incidence rate of PVCRBSI increased from 0.06 to 0.13 episodes/1,000 patient-days. A Gram-negative bacterial etiology was demonstrated in 162 (22.8%) episodes. There was a significant increase in the proportion of Gram-negative infections (22.6% in 1992 to 1996 versus 33.2% in 2012 to 2016). Independent predictive factors of Gram-negative PVCRBSI were the following: being in the hospital for more than 7 days with a catheter in situ for more than 3 days (adjusted odds ratio [aOR], 1.80; 95% confidence interval [CI], 1.20 to 2.69), surgery in the previous month (aOR, 2.39; 95% CI, 1.40 to 4.09), and antimicrobial treatment with beta-lactams (aOR, 1.80; 95% CI, 1.16 to 2.78). In conclusion, we reported an increase in the prevalence of Gram-negative PVCRBSI over the last 25 years. Factors associated with a Gram-negative bacterial etiology were being in the hospital for more than 7 days with a catheter in situ for more than 3 days, having undergone surgery, and having received antimicrobial treatment with beta-lactams.
Copyright © 2018 American Society for Microbiology.

Entities:  

Keywords:  Gram negative; bacteremia; bloodstream infections; peripheral venous catheter; phlebitis

Mesh:

Substances:

Year:  2018        PMID: 30126952      PMCID: PMC6201066          DOI: 10.1128/AAC.00892-18

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  29 in total

Review 1.  The risk of bloodstream infection in adults with different intravascular devices: a systematic review of 200 published prospective studies.

Authors:  Dennis G Maki; Daniel M Kluger; Christopher J Crnich
Journal:  Mayo Clin Proc       Date:  2006-09       Impact factor: 7.616

2.  Nationwide study on the use of intravascular catheters in internal medicine departments.

Authors:  M Guembe; M J Pérez-Granda; J A Capdevila; J Barberán; B Pinilla; P Martín-Rabadán; E Bouza
Journal:  J Hosp Infect       Date:  2015-02-26       Impact factor: 3.926

3.  Evolution and aetiological shift of catheter-related bloodstream infection in a whole institution: the microbiology department may act as a watchtower.

Authors:  M Rodríguez-Créixems; P Muñoz; P Martín-Rabadán; E Cercenado; M Guembe; E Bouza
Journal:  Clin Microbiol Infect       Date:  2013-04-09       Impact factor: 8.067

4.  Predominance of Gram-negative bacilli among patients with catheter-related bloodstream infections.

Authors:  E Braun; K Hussein; Y Geffen; G Rabino; Y Bar-Lavie; M Paul
Journal:  Clin Microbiol Infect       Date:  2014-02-20       Impact factor: 8.067

5.  Reduction of catheter-related bloodstream infections through the use of a central venous line bundle: epidemiologic and economic consequences.

Authors:  James S Kim; Paul Holtom; Cheryl Vigen
Journal:  Am J Infect Control       Date:  2011-06-08       Impact factor: 2.918

6.  Clinical epidemiology and outcomes of peripheral venous catheter-related bloodstream infections at a university-affiliated hospital.

Authors:  M Pujol; A Hornero; M Saballs; M J Argerich; R Verdaguer; M Cisnal; C Peña; J Ariza; F Gudiol
Journal:  J Hosp Infect       Date:  2007-08-27       Impact factor: 3.926

7.  Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012.

Authors:  R P Dellinger; Mitchell M Levy; Andrew Rhodes; Djillali Annane; Herwig Gerlach; Steven M Opal; Jonathan E Sevransky; Charles L Sprung; Ivor S Douglas; Roman Jaeschke; Tiffany M Osborn; Mark E Nunnally; Sean R Townsend; Konrad Reinhart; Ruth M Kleinpell; Derek C Angus; Clifford S Deutschman; Flavia R Machado; Gordon D Rubenfeld; Steven Webb; Richard J Beale; Jean-Louis Vincent; Rui Moreno
Journal:  Intensive Care Med       Date:  2013-01-30       Impact factor: 17.440

8.  Catheter-related bloodstream infections caused by Gram-negative bacteria.

Authors:  E Bouza; A Eworo; A Fernández Cruz; E Reigadas; M Rodríguez-Créixems; P Muñoz
Journal:  J Hosp Infect       Date:  2013-09-18       Impact factor: 3.926

Review 9.  Clinically-indicated replacement versus routine replacement of peripheral venous catheters.

Authors:  Joan Webster; Sonya Osborne; Claire M Rickard; Karen New
Journal:  Cochrane Database Syst Rev       Date:  2015-08-14

10.  Peripheral venous catheter-related bloodstream infection is associated with severe complications and potential death: a retrospective observational study.

Authors:  Akihiro Sato; Itaru Nakamura; Hiroaki Fujita; Ayaka Tsukimori; Takehito Kobayashi; Shinji Fukushima; Takeshi Fujii; Tetsuya Matsumoto
Journal:  BMC Infect Dis       Date:  2017-06-17       Impact factor: 3.090

View more
  4 in total

1.  Blood stream infections associated with central and peripheral venous catheters.

Authors:  Jose Manuel Ruiz-Giardin; Iciar Ochoa Chamorro; Laura Velázquez Ríos; Jeronimo Jaqueti Aroca; Maria Isabel García Arata; Juan Víctor SanMartín López; Marta Guerrero Santillán
Journal:  BMC Infect Dis       Date:  2019-10-15       Impact factor: 3.090

Review 2.  Ceftobripole: Experience in staphylococcal bacteremia.

Authors:  A Soriano; L Morata
Journal:  Rev Esp Quimioter       Date:  2019-09       Impact factor: 1.553

Review 3.  Possible clinical indications of ceftobiprole.

Authors:  J Barberán
Journal:  Rev Esp Quimioter       Date:  2019-09       Impact factor: 1.553

4.  Trends in the epidemiology of catheter-related bloodstream infections; towards a paradigm shift, Spain, 2007 to 2019.

Authors:  Laia Badia-Cebada; Judit Peñafiel; Patrick Saliba; Marta Andrés; Jordi Càmara; Dolors Domenech; Emili Jiménez-Martínez; Anna Marrón; Encarna Moreno; Virginia Pomar; Montserrat Vaqué; Enric Limón; Úrsula Masats; Miquel Pujol; Oriol Gasch
Journal:  Euro Surveill       Date:  2022-05
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.